2019 American Transplant Congress » Poster Session D: Kidney Acute Antibody Mediated Rejection

6:00pm-7:00pm

A Clinical Analysis for Low-Dose Immunoglobulin United with Plasmapheresis in High Sensitization Renal Transplantation Recipients

L. Xu¹, J. Zhang²

6:00pm-7:00pm

ABMR In Low-single Dose Thymoglobulin Induction Protocol In Renal Transplant Recepients From A Tertiary Care Centre In A Developing Country

R. Parthasarathy¹, M. Mohammed¹, P. Koshy², I. Pradeep², M. Mathew¹, G. Abraham¹

6:00pm-7:00pm

Adjunctive Therapy With Tocilizumab For Treatment Of Acute Antibody Mediated Rejection – 2 Year Experience

K. Venkatachalam, R. Delos Santos, B. Heady, A. Malone, T. Alhamad

6:00pm-7:00pm

Association between CD19-Positive Rate and Antibody-Mediated Rejection Following Rituximab Administration in Kidney Transplant Recipients

K. Nanmoku, T. Shinzato, T. Kubo, T. Shimizu, T. Yagisawa

6:00pm-7:00pm

Cluster Analysis of Microvascular Inflammation in Indication Biopsies Unveils Distinct Pathological and Immunological Phenotypes with Prognostic Implications

J. Malheiro¹, A. Silva¹, S. Santos¹, S. Tafulo², L. Martins¹, L. Dias¹, A. Castro-Henriques¹

6:00pm-7:00pm

Daratumumab for Treatment of Antibody-Mediated Rejection in a Kidney Transplant Recipient

S. C. Jordan¹, R. Vescio², M. Toyoda³, N. Ammerman¹, E. Huang¹, A. Peng¹, S. Sethi¹, R. Najjar¹, K. Lim¹, A. Vo¹

6:00pm-7:00pm

De Novo Complement-Activating Donor Specific Antibodies in Pediatric Renal Transplant Recipients Are Highly Responsive to Therapy

V. Sigurjonsdottir, A. Chaudhuri, P. Grimm

6:00pm-7:00pm

Do Outcomes Differ in Glomerulitis Predominant Antibody Mediated Rejection and Peritubular capillaritis Predominant Antibody Mediated Rejection?

S. Sethi¹, J. Hou², M. Lin², Y. Ren², A. Peng¹, R. Najjar¹, A. Vo¹, S. Jordan¹, M. Haas², E. Huang¹

6:00pm-7:00pm

Donor-Derived Cell-Free DNA (dd-cfDNA) Course after Rejection in Pediatric Kidney Transplant Recipients

R. D. Swinford¹, A. M. De Golovine¹, C. Bell¹, A. Pai¹, A. R. Edwards¹, S. Connor², J. S. Bynon¹

6:00pm-7:00pm

Effect of Race and Antibody-Mediated Injury on Outcomes after Early Subclinical Inflammation

E. P. Kasik, M. E. Seifert, M. Bernard, G. Agarwal, H. Fatima, R. Gaston, B. Julian, C. Kew, V. Kumar, S. Mehta, S. Ong, F. Rosenblum, G. Towns, R. B. Mannon

6:00pm-7:00pm

Evaluation Of Complement-related Factors In Tma Post-kidney Transplantation: A Retrospective Multicenter Study

N. Fujiyama¹, M. Tasaki², H. Harada³, K. Tsutahara⁴, A. Matsumoto⁵, Y. Hara⁶, M. Okumi⁷, K. Saito², Y. Watarai⁸, N. Inoue⁹, N. Wakamiya⁹, S. Satoh¹

6:00pm-7:00pm

Immediate Post Reperfusion In Vivo Transcriptional Responses of Individual Human Renal Allograft Cell Populations to Circulating Anti-Angiotensin II Type I Receptor Antibody

C. M. Castro -Rojas¹, N. Salomonis², K. Chetal², R. R. Alloway³, E. Woodle³, D. A. Hildeman¹

6:00pm-7:00pm

Impact of Granulocyte Colony Stimulating Factor on Clinical Outcomes in Kidney Transplant Recipients with Neutropenia

H. Yao¹, A. Alam², R. Sapir-Pichhadze², D. D’Arienzo³, D. Baran², S. Sandal², M. Cantarovich²

6:00pm-7:00pm

Incidence of De Novo Donor Specific Antibodies and Treatment Response for AMR in Pediatric Kidney Transplant Recipients

S. Gattis¹, R. Liverman¹, A. Serluco¹, J. Yin¹, H. C. Sullivan², R. A. Bray³, H. M. Gebel³, S. Jernigan⁴, R. George⁴, P. D. Winterberg⁴, R. Garro⁴

6:00pm-7:00pm

Induction Therapy Modulated by the Absence of Preformed Donor-Specific Antibodies (DSAS) Regardless of the Level of Sensitization

M. Cristelli, K. Linhares, R. de Marco, L. Viana, C. Felipe, M. Gaspar, C. Peixoto, G. Marcelo Gomes, J. Toniato Rezende, K. Nunes Ficher, L. Alfaro Villanueva, V. Lima, M. Gerbase de Lima, J. Medina Pestana, H. Tedesco Silva Junior

6:00pm-7:00pm

Infectious Complications after Treatment of Antibody-Mediated Kidney Allograft Rejection: A National Cohort Study

N. Perrottet¹, D. Golshayan², O. Manuel², V. Aubert², M. Koller³, K. Hadaya⁴, L. Bühler⁴, T. Mueller⁵, U. Huynh-Do⁶, S. Dahdal⁶, I. Binet⁷, M. Dickenmann³, S. Schaub³, J. Steiger³, M. Pascual², M. Fernández-Ruiz²

6:00pm-7:00pm

International Multicenter Study Evaluating Clinical Outcomes Associated with Acute Antibody-Mediated Rejection

S. Corman¹, I. Hirji², E. Brouwer², S. H. Park¹, C. Macahilig³, A. Vergani², T. Bo², P. Wolthoff³, P. Keown⁴

6:00pm-7:00pm

Is HLA Donor-Specific Antibody (DSA)-C3d+ Assay a Potential Predictor of Subclinical Antibody Mediated Damage in the Renal Graft?

A. G. Contreras¹, M. I. Solis-G¹, C. Ramirez-Espinoza¹, J. Hernandez-Rosales², M. Vilatoba-Chapa¹, R. Cruz-Martínez¹, J. Granados¹, L. E. Morales-Buenrostro³, J. Alberú¹, J. M. Arreola-Guerra⁴

6:00pm-7:00pm

Is Pre-transplant Plasmapheresis For Patients With Insignificant Abo Blood Type Antibody In Abo Blood Type Incompatible Kidney Transplant Necessary? – A Japanese Single Center Study.

M. Miyazaki, A. Mitsuke, H. Higuchi, N. Fukuzawa, H. Tanaka, T. Hirano, T. Seki, H. Harada

6:00pm-7:00pm

Outcomes Of Treatment Of Late Vs Early Acute Antibody-mediated Rejection In Renal Transplant Recipients – A Single Center Experience

R. Prashar, N. Sulejmani, A. Patel

6:00pm-7:00pm

Peritubular Capillary C4d Positivity in Renal Allograft Biopsies: Implications for Allograft Survival

A. Bailey, S. Tremblay, A. R. Shields, J. Wang, R. Alloway, E. S. Woodle

6:00pm-7:00pm

Post-Transplant Anti- A Titer >1:128 in A2-Incompatible Kidney Recipients is Associated with Subclinical Antibody Mediated Rejection

V. Kumar, D. Williams, P. MacLennan, M. Mustian, B. Orandi, L. Williams, J. Locke

6:00pm-7:00pm

Pre-emptive Ivig For Dsa Positive Living Donor Kidney Transplant Recipients

B. Abdalla¹, D. Kellner², A. Diaz², Y. Zheng³, E. Reed⁴, Q. J. Zhang⁴

6:00pm-7:00pm

Reduced Intensity Induction Therapy in Patients Undergoing Repeat Kidney Transplants

K. Linhares, M. Cristelli, C. Felipe, L. Viana, H. Proença, R. E. de Marco, J. Pestana, H. Tedesco

6:00pm-7:00pm

Use of Eculizumab for Active Antibody-Mediated Rejection That Occurs Early Post-Kidney Transplantation: A Consecutive Series of 15 Cases

E. Tan¹, B. J. Andrew², P. G. Dean², M. F. Shaheen¹, M. D. Stegall², C. A. Schinstock²

6:00pm-7:00pm

Yellow Fever and Renal Transplantation: Influence of Vaccination and Infection on the Emergence of Antibody-Mediated Rejection

M. V. Sousa¹, R. L. Zollner², R. S. Stucchi³, I. F. Boin⁴, E. C. Ataide⁴, M. Mazzali¹